機関投資家の保有一覧

Ikarian Capital, LLC

持ち方

—

評価額を取得中

届出上位5銘柄の比重

—

保有

124銘柄

Ikarian Capital, LLC は、2026年6月30日の SEC Form 13F で 124 銘柄の保有を報告しました。届出上位には Kodiak Sciences、Abivax、Vaxcyte が並び、ヘルスケアにまたがります。下の銘柄名と保有株数は届出に基づきます。

届出上位の10銘柄

1
KO
KODKodiak Sciences
ヘルスケア・ 1,059,730 株
—
2
AB
ABVXAbivax
ヘルスケア・ 328,635 株
—
3
PC
PCVXVaxcyte
ヘルスケア・ 388,682 株
—
4
PR
PRAXPraxis Precision Medicines
ヘルスケア・ 72,842 株
—
5
AN
ANIPANI Pharmaceuticals
ヘルスケア・ 272,085 株
—
6
CL
CLDXCelldex Therapeutics
ヘルスケア・ 478,500 株
—
7
RC
RCUSArcus Biosciences
ヘルスケア・ 504,559 株
—
8
CO
COGTCogent Biosciences
ヘルスケア・ 370,084 株
—
9
CT
CTNMContineum Therapeutics
ヘルスケア・ 807,874 株
—
10
AN
ANROAlto Neuroscience
ヘルスケア・ 407,338 株
—

残り 114 銘柄をすべて見る ▾

#	銘柄	保有株数	概算評価額
11	MAZEMaze Therapeutics	378,999	—
12	PHVSPharvaris	308,856	—
13	BHVNBiohaven	748,181	—
14	VERAVera Therapeutics	310,000	—
15	SLNSilence Therapeutics	830,784	—
16	VRDNViridian Therapeutics	425,000	—
17	RLMDRelmada Therapeutics	2,148,359	—
18	ACOGAlpha Cognition	836,259	—
19	CCCCC4 Therapeutics	2,433,000	—
20	DMRADamora Bio	335,710	—
21	JBIOJade Biosciences	427,349	—
22	ALMSAlumis	870,548	—
23	ELVNEnliven Therapeutics	126,541	—
24	EPRXEupraxia Pharmaceuticals	809,741	—
25	PRQRProQR Therapeutics	3,425,930	—
26	SPRBSpruce Biosciences	121,356	—
27	DBVTDBV Technologies	525,000	—
28	HIMSHims & Hers Health	188,381	—
29	CAPRCapricor Therapeutics	604,215	—
30	OVIDOvid Therapeutics	2,269,704	—
31	PTHSPelthos Therapeutics	256,598	—
32	ZURAZura Bio	1,218,492	—
33	CRDLCardiol Therapeutics	3,325,000	—
34	TECXTectonic Therapeutic	205,837	—
35	DRUGBright Minds Biosciences	88,951	—
36	CNTBConnect Biopharma	4,538,534	—
37	HROWHarrow	135,775	—
38	OCGNOcugen	3,962,972	—
39	IVAInventiva	1,129,101	—
40	ABSIAbsci	353,772	—
41	FULCFulcrum Therapeutics	1,049,161	—
42	BBIOBridgeBio Pharma	57,417	—
43	RZLTRezolute	935,012	—
44	MNPRMonopar Therapeutics	47,861	—
45	CPIXCumberland Pharmaceuticals	503,153	—
46	KZIAKazia Therapeutics	396,201	—
47	ALECAlector	1,982,606	—
48	QTTBQ32 Bio	430,000	—
49	CLYMClimb Bio	300,000	—
50	AMLXAmylyx Pharmaceuticals	117,500	—
51	OLMAOlema Pharmaceuticals	383,281	—
52	DCTHDelcath Systems	185,667	—
53	CUECue Biopharma	104,364	—
54	ARVNArvinas	358,257	—
55	RAREUltragenyx Pharmaceutical	165,617	—
56	ARWRArrowhead Pharmaceuticals	38,278	—
57	RNTXRein Therapeutics	2,950,000	—
58	TARSTarsus Pharmaceuticals	31,166	—
59	IVVDInvivyd	2,656,570	—
60	ABOSAcumen Pharmaceuticals	1,053,797	—
61	QNCXQuince Therapeutics	72,251	—
62	PMNProMIS Neurosciences	205,000	—
63	LXEOLexeo Therapeutics	513,011	—
64	ANNXAnnexon	430,244	—
65	DERMJourney Medical	251,436	—
66	VSTMVerastem	213,865	—
67	AMANAmanat Acquisition Corp.	150,000	—
68	TENXTenax Therapeutics	787,600	—
69	HELPCybin	132,153	—
70	STIMNeuronetics	701,182	—
71	NXTCNextCure	288,303	—
72	TRAXFirst Tracks Biotherapeutics	42,775	—
73	CABACabaletta Bio	700,000	—
74	AVTXAvalo Therapeutics	90,183	—
75	BIOABioAge Labs	200,000	—
76	AVRAnteris Technologies	166,571	—
77	IMNMImmunome	60,000	—
78	IBIOiBio	957,062	—
79	PALIPalisade Bio	750,000	—
80	LPCNLipocine	508,556	—
81	PLRXPliant Therapeutics	1,000,000	—
82	PEPGPepGen	447,165	—
83	FTHFaeth Therapeutics	35,386	—
84	KLRSKalaris Therapeutics	360,000	—
85	QNRXQuoin Pharmaceuticals	211,538	—
86	CNSPCNS Pharmaceuticals	135,830	—
87	NMRANeumora Therapeutics	1,278,408	—
88	ACADACADIA Pharmaceuticals	28,099	—
89	IMUXImmunic	67,464	—
90	ANLAdlai Nortye	33,899	—
91	GUTSFractyl Health	1,100,000	—
92	EQEquillium	303,555	—
93	PASGPassage Bio	99,517	—
94	LYELLyell Immunopharma	41,081	—
95	IMTXImmatics	48,569	—
96	PURRHyperliquid Strategies	30,001	—
97	INMInMed Pharmaceuticals	245,025	—
98	WVEWave Life Sciences	85,285	—
99	LXRXLexicon Pharmaceuticals	164,674	—
100	SLDBSolid Biosciences	42,956	—
101	VKTXViking Therapeutics	9,717	—
102	TRAWTraws Pharma	478,142	—
103	MGNXMacroGenics	74,893	—
104	EVAXEvaxion	74,698	—
105	ELTXElicio Therapeutics	100,000	—
106	CMPSCOMPASS Pathways	15,000	—
107	NEUPNeuphoria Therapeutics	47,443	—
108	PMVPPMV Pharmaceuticals	89,136	—
109	RNACCartesian Therapeutics	20,807	—
110	ENVBEnveric Biosciences	100,002	—
111	VTGNVistagen Therapeutics	519,077	—
112	BCRXBioCryst Pharmaceuticals	16,756	—
113	VYGRVoyager Therapeutics	53,063	—
114	AEMDAethlon Medical	14,364	—
115	CMMBChemomab Therapeutics	51,793	—
116	NYXHNyxoah	47,358	—
117	MGRXMangoceuticals	138,146	—
118	GCTKGlucotrack	45,830	—
119	AIRSAirSculpt Technologies	16,398	—
120	TOVXTheriva Biologics	112,076	—
121	CMPXCompass Therapeutics	18,000	—
122	JSPRJasper Therapeutics	24,093	—
123	PHGEPHGE	19,473	—
124	FBRXFBRX	20,972	—

2026年6月30日時点の SEC への Form 13F 届出 (運用資産 $100M 以上の機関投資家が四半期ごとに提出) の集計。届出は四半期末から最大45日遅れで公開されるため、現在の保有と異なる場合があります。概算評価額と構成比は当サイトの株価で計算した参考値です。届出対象外の資産 (米国外上場株・債券など) は含まれません。